CII
KRTX

Capital International Inc’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Capital International Inc’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-13,632
Closed -$4.31M – 337
2023
Q4 		$4.31M Buy
13,632
+7,684
+129% +$1.49M 0.07% 211
2023
Q3 		$1.01M Sell
5,948
-1,134
-16% -$213K 0.02% 276
2023
Q2 		$1.54M Buy
+7,082
New +$1.52M 0.03% 260
2021
Q3 		– Sell
-190,923
Closed -$21.8M – 310
2021
Q2 		$21.8M Sell
190,923
-15,941
-8% -$1.86M 0.19% 130
2021
Q1 		$24.9M Sell
206,864
-22,003
-10% -$2.49M 0.23% 120
2020
Q4 		$23.3M Sell
228,867
-2,789
-1% -$258K 0.22% 121
2020
Q3 		$17.9M Hold
231,656
– – 0.2% 123
2020
Q2 		$25.8M Buy
231,656
+4,318
+2% +$375K 0.31% 107
2020
Q1 		$16.4M Buy
+227,338
New +$19.4M 0.28% 102

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Capital International Inc's KRTX Position: Q1 2024 in Review

Capital International Inc sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 13,632 shares — an estimated $4.31M sold.

Capital International Inc first reported a position in KRTX in Q1 2020 and held it in 9 quarters. The position peaked at $25.8M in Q2 2020. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Capital International Inc reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Capital International Inc sold 13,632 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $4.31M.
  • Capital International Inc first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2020 and held it in 9 quarters.
  • Capital International Inc's Karuna Therapeutics, Inc. Common Stock position peaked at $25.8M in Q2 2020.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Capital International Inc's 13F filing for Q1 2024, filed 14 May 2024.